Recent collaborative efforts have subclassified malignant glioblastomas into 4 clinical relevant subtypes based on their signature genetic lesions. Platelet-derived growth factor receptor α (PDGFRA) overexpression is concomitant with a loss of cyclin-dependent kinase inhibitor 2A (CDKN2A) locus (encoding P16INK4A and P14ARF) in a large number of tumors within one subtype of glioblastomas. Here we report that activation of PDGFRα conferred tumorigenicity to Ink4a/Arf-deficient mouse astrocytes and human glioma cells in the brain. Restoration of p16INK4a but not p19ARF suppressed PDGFRα-promoted glioma formation. Mechanistically, abrogation of signaling modules in PDGFRα that lost capacity to bind to SHP-2 or PI3K significantly diminished PDGFRα-promoted tumorigenesis. Furthermore, inhibition of SHP-2 by shRNAs or pharmacological inhibitors disrupted the interaction of PI3K with PDGFRα, suppressed downstream AKT/mTOR activation, and impaired tumorigenesis of Ink4a/Arf-null cells, whereas expression of an activated PI3K mutant rescued the effect of SHP-2 inhibition on tumorigenicity. PDGFRα and PDGF-A are co-expressed in clinical glioblastoma specimens, and such co-expression is linked with activation of SHP-2/AKT/mTOR signaling. Together, our data suggest that in glioblastomas with Ink4a/Arf deficiency, overexpressed PDGFRα promotes tumorigenesis through the PI3K/AKT/mTOR-mediated pathway regulated by SHP-2 activity. These findings functionally validate the genomic analysis of glioblastomas and identify SHP-2 as a potential target for treatment of glioblastomas.
Kun-Wei Liu, Haizhong Feng, Robert Bachoo, Andrius Kazlauskas, Erin M. Smith, Karen Symes, Ronald L. Hamilton, Motoo Nagane, Ryo Nishikawa, Bo Hu, Shi-Yuan Cheng
Title and authors | Publication | Year |
---|---|---|
Multi-scale signaling and tumor evolution in high-grade gliomas.
Liu J, Cao S, Imbach KJ, Gritsenko MA, Lih TM, Kyle JE, Yaron-Barir TM, Binder ZA, Li Y, Strunilin I, Wang YT, Tsai CF, Ma W, Chen L, Clark NM, Shinkle A, Naser Al Deen N, Caravan W, Houston A, Simin FA, Wyczalkowski MA, Wang LB, Storrs E, Chen S, Illindala R, Li YD, Jayasinghe RG, Rykunov D, Cottingham SL, Chu RK, Weitz KK, Moore RJ, Sagendorf T, Petyuk VA, Nestor M, Bramer LM, Stratton KG, Schepmoes AA, Couvillion SP, Eder J, Kim YM, Gao Y, Fillmore TL, Zhao R, Monroe ME, Southard-Smith AN, Li YE, Jui-Hsien Lu R, Johnson JL, Wiznerowicz M, Hostetter G, Newton CJ, Ketchum KA, Thangudu RR, Barnholtz-Sloan JS, Wang P, Fenyö D, An E, Thiagarajan M, Robles AI, Mani DR, Smith RD, Porta-Pardo E, Cantley LC, Iavarone A, Chen F, Mesri M, Nasrallah MP, Zhang H, Resnick AC, Chheda MG, Rodland KD, Liu T, Ding L |
Cancer cell | 2024 |
Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q, Yu B, Zhang Y, Yang Y, Xu C, Zhang M, Chen G, Luo F, Sun B, Yang R, Li Y, Feng H |
Cellular oncology (Dordrecht) | 2023 |
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade.
Donini C, Galvagno F, Rotolo R, Massa A, Merlini A, Scagliotti GV, Novello S, Bironzo P, Leuci V, Sangiolo D |
British Journal of Cancer | 2023 |
Long-term environmental metal exposure is associated with hypomethylation of CpG sites in NFKB1 and other genes related to oncogenesis.
Stepanyan A, Petrackova A, Hakobyan S, Savara J, Davitavyan S, Kriegova E, Arakelyan A |
Clinical Epigenetics | 2023 |
Oncogenic long noncoding RNA LINC02283 enhances PDGF receptor A-mediated signaling and drives glioblastoma tumorigenesis.
Goenka A, Song X, Tiek D, Iglesia RP, Lu M, Zeng C, Horbinski C, Zhang W, Hu B, Cheng SY |
Neuro-Oncology | 2023 |
Tumor radiogenomics in gliomas with Bayesian layered variable selection
Mohammed S, Kurtek S, Bharath K, Rao A, Baladandayuthapani V |
Medical image analysis | 2023 |
Complex Roles of PTPN11/SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy
Scheiter A, Lu LC, Gao LH, Feng GS |
Annual review of cancer biology | 2023 |
Identification of novel proteins for lacunar stroke by integrating genome-wide association data and human brain proteomes
Zhang C, Qin F, Li X, Du X, Li T |
BMC Medicine | 2022 |
Molecular Genetics and Targeted Therapies for Paediatric High-grade Glioma
RALLIS KS, GEORGE AM, WOZNIAK AM, BIGOGNO CM, CHOW B, HANRAHAN JG, SIDERIS M |
Cancer genomics & proteomics | 2022 |
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy
Tang X, Qi C, Zhou H, Liu Y |
Frontiers in Oncology | 2022 |
Probabilistic edge inference of gene networks with markov random field-based bayesian learning
Huang YJ, Mukherjee R, Hsiao CK |
Frontiers in Genetics | 2022 |
Current understanding of gliomagenesis: from model to mechanism
Luo J, Junaid M, Hamid N, Duan JJ, Yang X, Pei DS |
International journal of medical sciences | 2022 |
The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin
G Peng, Y Wang, P Ge, C Bailey, P Zhang, D Zhang, Z Meng, C Qi, Q Chen, J Chen, J Niu, P Zheng, Y Liu, Y Liu |
Journal of Experimental & Clinical Cancer Research | 2021 |
Non-canonical PD-1 signaling in cancer and its potential implications in clinic
H Zha, Y Jiang, , J Shang, N Wang, L Yu, W Zhao, Z Li, J An, X Zhang, H Chen, B Zhu, Z Li |
Journal for ImmunoTherapy of Cancer | 2021 |
Prenatal overexpression of platelet‐derived growth factor receptor A results in central nervous system hypomyelination
HJ Cardona, A Somasundaram, DM Crabtree, SL Gadd, OJ Becher |
Brain and Behavior | 2021 |
Rates and patterns of clonal oncogenic mutations in the normal human brain
Ganz J, Maury EA, Becerra B, Bizzotto S, Doan RN, Kenny CJ, Shin T, Kim J, Zhou Z, Ligon KL, Alice Lee E, Walsh CA |
Cancer Discovery | 2021 |
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
W Yu, Y Hua, H Qiu, J Hao, K Zou, Z Li, S Hu, P Guo, M Chen, S Sui, Y Xiong, F Li, J Lu, W Guo, G Luo, W Deng |
Cell Death and Disease | 2020 |
Pediatric low-grade glioma in the era of molecular diagnostics
S Ryall, U Tabori, C Hawkins |
Acta Neuropathologica Communications | 2020 |
SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
L Zhang, C Yuan, J Peng, L Zhou, Y Jiang, Y Lin, W Yin, S Xu, J Ma, J Lu |
Frontiers in Oncology | 2020 |
Genetic characterization of an aggressive optic nerve pilocytic glioma
CS Hong, G Fliney, A Fisayo, Y An, PP Gopal, A Omuro, R Pointdujour-Lim, EZ Erson-Omay, SB Omay |
Brain Tumor Pathology | 2020 |
Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response
Y Wang, Y Hou, W Zhang, AA Alvarez, Y Bai, B Hu, SY Cheng, K Yang, Y Li, H Feng |
Journal of Experimental & Clinical Cancer Research | 2019 |
Rare Pediatric Invasive Gliofibroma Has BRAF V600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution
K Kaneva, KK Yeo, D Hawes, J Ji, JA Biegel, MD Nelson, S Bluml, MD Krieger, A Erdreich-Epstein |
JCO Precision Oncology | 2019 |
An allosteric inhibitor of SHP2 effectively targets PDGFRα-driven glioblastoma
BA Tannous, CE Badr |
Neuro-Oncology | 2019 |
Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2–mediated signaling
Y Sang, Y Hou, R Cheng, L Zheng, AA Alvarez, B Hu, SY Cheng, W Zhang, Y Li, H Feng |
Neuro-Oncology | 2019 |
Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells
J Wang, P Sun, Y Chen, H Yao, S Wang |
Scientific Reports | 2018 |
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
M Zhao, W Guo, Y Wu, C Yang, L Zhong, G Deng, Y Zhu, W Liu, Y Gu, Y Lu, L Kong, X Meng, Q Xu, Y Sun |
Acta pharmaceutica Sinica. B | 2018 |
Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells
AW Hall, AM Battenhouse, H Shivram, AR Morris, MC Cowperthwaite, M Shpak, VR Iyer |
Cancer research | 2018 |
piRNA-8041 is downregulated in human glioblastoma and suppresses tumor growth in vitro and in vivo
DI Jacobs, Q Qin, A Fu, Z Chen, J Zhou, Y Zhu |
Oncotarget | 2018 |
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
D Lv, Y Li, W Zhang, AA Alvarez, L Song, J Tang, WQ Gao, B Hu, SY Cheng, H Feng |
Nature Communications | 2017 |
T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice
W Liu, W Guo, L Shen, Z Chen, Q Luo, X Luo, GS Feng, Y Shu, Y Gu, Q Xu, Y Sun |
Oncotarget | 2017 |
EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines
D Chakravarty, AM Pedraza, J Cotari, AH Liu, D Punko, A Kokroo, JT Huse, G Altan-Bonnet, CW Brennan |
Scientific Reports | 2017 |
SHP2 regulates proliferation and tumorigenicity of glioma stem cells
L Roccograndi, ZA Binder, L Zhang, N Aceto, Z Zhang, M Bentires-Alj, I Nakano, N Dahmane, DM ORourke |
Journal of Neuro-Oncology | 2017 |
PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway
J Singh, K Sharma, PP Pillai |
Cytotechnology | 2017 |
Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding
D Lv, F Jia, Y Hou, Y Sang, AA Alvarez, W Zhang, WQ Gao, B Hu, SY Cheng, J Ge, Y Li, H Feng |
Cancer research | 2017 |
SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial–mesenchymal transition and invasion in mice and humans
L Zhang, W Zhang, Y Li, A Alvarez, Z Li, Y Wang, L Song, D Lv, I Nakano, B Hu, SY Cheng, H Feng |
Oncogene | 2016 |
Pediatric gliomas as neurodevelopmental disorders: Developmental Biology of Childhood Gliomas
SJ Baker, DW Ellison, DH Gutmann |
Glia | 2015 |
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
S Kleffel, C Posch, SR Barthel, H Mueller, C Schlapbach, E Guenova, CP Elco, N Lee, VR Juneja, Q Zhan, CG Lian, R Thomi, W Hoetzenecker, A Cozzio, R Dummer, MC Mihm, KT Flaherty, MH Frank, GF Murphy, AH Sharpe, TS Kupper, T Schatton |
Cell | 2015 |
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis
S Bunda, K Burrell, P Heir, L Zeng, A Alamsahebpour, Y Kano, B Raught, ZY Zhang, G Zadeh, M Ohh |
Nature Communications | 2015 |
Cell of Origin for Malignant Gliomas and Its Implication in Therapeutic Development
H Zong, LF Parada, SJ Baker |
Cold Spring Harbor perspectives in biology | 2015 |
EGFR Phosphorylation of DCBLD2 Recruits TRAF6 and Stimulates Akt-promoted Tumorigenesis
Haizhong Feng, Giselle Lopez, Chung Kwon Kim, Angel Alvarez, Christopher Duncan, Ryo Nishikawa, Motoo Nagane, An-jey Su, Philip Auron, Matthew Hedberg, Lin Wang, Jeffrey Raizer, John A. Kessler, Andrew Parsa, Wei-Qiang Gao, Sung-Hak Kim, Mutsuko Minanta, Ichiro Nakano, Jennifer R. Grandis, Roger McLendon, Darell Bigner, Hui-Kuan Lin, Frank Furnari, Webster K. Cavenee, Bo Hu, Hai Yan, Shi-Yuan Cheng |
Journal of Clinical Investigation | 2014 |
The Genetic Signatures of Pediatric High-Grade Glioma: No Longer a One-Act Play
AK Diaz, SJ Baker |
Seminars in radiation oncology | 2014 |
MicroRNA Profiling Reveals Unique miRNA Signatures in IGF-1 Treated Embryonic Striatal Stem Cell Fate Decisions in Striatal Neurogenesis In Vitro
S Pati, NE Supeno, S Muthuraju, RA Hadi, AR Ghani, FM Idris, M Maletic-Savatic, JM Abdullah, H Jaafar |
BioMed Research International | 2014 |
Protein kinase A-dependent phosphorylation of Dock180 at serine residue 1250 is important for glioma growth and invasion stimulated by platelet derived growth factor receptor
H Feng, Y Li, Y Yin, W Zhang, Y Hou, L Zhang, Z Li, B Xie, WQ Gao, JN Sarkaria, JJ Raizer, CD James, AT Parsa, B Hu, SY Cheng |
Neuro-Oncology | 2014 |
Targeting the PDGF signaling pathway in tumor treatment
CH Heldin |
Cell Communication and Signaling | 2013 |
A Reactive Oxygen Species-Mediated, Self-Perpetuating Loop Persistently Activates Platelet-Derived Growth Factor Receptor
H Lei, A Kazlauskas |
Molecular and cellular biology | 2013 |
EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180
H Feng, B Hu, K Vuori, JN Sarkaria, FB Furnari, WK Cavenee, SY Cheng |
Oncogene | 2013 |
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
BS Paugh, X Zhu, C Qu, R Endersby, AK Diaz, J Zhang, DA Bax, D Carvalho, RM Reis, A Onar-Thomas, A Broniscer, C Wetmore, J Zhang, C Jones, DW Ellison, SJ Baker |
Cancer research | 2013 |
Heparan Sulfate Sulfatase SULF2 Regulates PDGFRα Signaling and Growth In Human and Mouse Malignant Glioma
Joanna Phillips, Emmanuelle Huillard, Aaron Robinson, Anna Ward, David Lum, Mei-Yin Polley, Steven Rosen, David Rowitch, Zena Werb |
Journal of Clinical Investigation | 2012 |
Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
NJ Szerlip, A Pedraza, D Chakravarty, M Azim, J McGuire, Y Fang, T Ozawa, EC Holland, JT Huse, S Jhanwar, MA Leversha, T Mikkelsen, CW Brennan |
Proceedings of the National Academy of Sciences | 2012 |
Review: insights gained from modelling high-grade glioma in the mouse
SL Rankin, G Zhu, SJ Baker |
Neuropathology and Applied Neurobiology | 2012 |
Novel therapeutic targets in the brain tumor microenvironment.
Phillips JJ |
Oncotarget | 2012 |
Novel Therapeutic Targets in the Brain Tumor Microenvironment
Phillips JJ |
Oncotarget | 2012 |
Activation of Rac1 by Src-dependent Phosphorylation of Dock180Y1811 Mediates PDGFRα-stimulated Glioma Tumorigenesis in Mice and Humans
Haizhong Feng, Bo Hu, Kun-wei Liu, Yanxin Li, Xinghua Lu, Tao Cheng, Jia-Jean Yiin, Songjian Lu, Susan Keezer, Tim Fenton, Frank Furnari, Ronald Hamilton, Kristiina Vuori, Jann Sarkaria, Motoo Nagane, Ryo Nishikawa, Webster K. Cavenee, Shi-Yuan Cheng |
Journal of Clinical Investigation | 2011 |
Platelet-derived growth factor signaling in human malignancies
KW Liu, B Hu, SY Cheng |
Chinese journal of cancer | 2011 |
Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion
H Feng, KW Liu, P Guo, P Zhang, T Cheng, MA McNiven, GR Johnson, B Hu, SY Cheng |
Oncogene | 2011 |
Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines
AR Hussain, S Uddin, R Bu, OS Khan, SO Ahmed, M Ahmed, KS Al-Kuraya |
PloS one | 2011 |
Platelet-derived growth factor receptor alpha in glioma: a bad seed
KW Liu, B Hu, SY Cheng |
Chinese journal of cancer | 2011 |
MicroRNAs as Regulators of Neural Stem Cell-Related Pathways in Glioblastoma Multiforme
P González-Gómez, P Sánchez, H Mira |
Molecular Neurobiology | 2011 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |